Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Virchows Archiv : an International Journal of Pathology
|
January 20, 2021
Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation
Katja Evert, Thomas Dienemann, Christoph Brochhausen, et al.
American Journal of Hematology
|
January 11, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
Jelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
BMC Cancer
|
October 22, 2018
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
Marlies Antlanger, Tobias Dust, Thomas Reiter, et al.
Wiener Klinische Wochenschrift
|
September 30, 2008
[The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases]
, Heinz Ludwig, Thomas Auberger, et al.
Expert Review of Hematology
|
July 26, 2023
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives
Peter Valent, Irina Sadovnik, Barbara Peter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 17, 2023
Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics
Niklas Abele, Katharina Tiemann, Till Krech, et al.
Blood
|
March 23, 2006
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, et al.
Wiener Klinische Wochenschrift
|
July 3, 2026
[Vaccination of immunocompromised individuals: Expert opinion - update 2026]
Ursula Wiedermann, Angelika Wagner, Alexander Bartuschka, et al.
Journal of Clinical Apheresis
|
September 1, 2016
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure
Nina Worel, Gerhard Fritsch, Hermine Agis, et al.
Blood
|
August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Virchows Archiv : an International Journal of Pathology
|
January 20, 2021
Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation
Katja Evert, Thomas Dienemann, Christoph Brochhausen, et al.
American Journal of Hematology
|
January 11, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
Jelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
BMC Cancer
|
October 22, 2018
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
Marlies Antlanger, Tobias Dust, Thomas Reiter, et al.
Wiener Klinische Wochenschrift
|
September 30, 2008
[The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases]
, Heinz Ludwig, Thomas Auberger, et al.
Expert Review of Hematology
|
July 26, 2023
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives
Peter Valent, Irina Sadovnik, Barbara Peter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 17, 2023
Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics
Niklas Abele, Katharina Tiemann, Till Krech, et al.
Blood
|
March 23, 2006
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, et al.
Wiener Klinische Wochenschrift
|
July 3, 2026
[Vaccination of immunocompromised individuals: Expert opinion - update 2026]
Ursula Wiedermann, Angelika Wagner, Alexander Bartuschka, et al.
Journal of Clinical Apheresis
|
September 1, 2016
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure
Nina Worel, Gerhard Fritsch, Hermine Agis, et al.
Blood
|
August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Page
of 9